Development, implementation and evaluation of an electronic medical record prompt for bone density testing.
The purpose of this study was to assess whether an electronic prompt promoting BMD testing affected the proportion of patients who received BMD and/or bone health medication. Rheumatology providers of patients 40+, on prednisone, with no record of BMD testing in the past 2 years, were targeted with the message: 'This patient is at risk for osteoporosis due to prednisone use. We have no record of a recent Dexa scan.' We also surveyed providers on the prompt's value. The use of prednisone remained stable; BMD testing was quite low in all periods but increased slightly (non-statistically) over time, as did bone health medication use. Providers found the prompt not tailored enough to be clinically meaningful. Electronic prompts seem beneficial in theory; however, putting them into practice has challenges. While the EMR has great potential to improve care, more needs to be done to ensure optimal use.
Rolnick
Sharon J
SJ
HealthPartners Research Foundation, Minneapolis, MN 55440-1524, USA. cheri.j.rolnick@healthpartners.com
Jackson
Jody M
JM
Amundson
Jerry H
JH
D015502:Absorptiometry, Photon / Q000706:statistics & numerical data*; D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D015519:Bone Density / Q000187:drug effects; D020000:Decision Support Systems, Clinical; D057286:Electronic Health Records; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis / Q000517:prevention & control; D011241:Prednisone / Q000494:pharmacology / Q000627:therapeutic use; D017010:Reminder Systems; D012219:Rheumatology
D000893:Anti-Inflammatory Agents; D011241:Prednisone